DIGNA BIOTECH

CIMA is active in four research areas related to heart, brain, cancer, and liver. These areas have been prioritized based of their importance to health care, their social impact, and the experience and research tradition inherent to the Schools of Medicine, Pharmacy and Science, and the Clínica Universidad de Navarra. The thematic priorities within each area are as follows:

• Cardiovascular physiopathology: hypertension, atherosclerosis and diabetes, thrombosis and hemostasia.
• Oncology: carcinogenesis, cell therapy and immunotherapy.
• Neuroscience: Parkinson’s and Alzheimer’s diseases.
• Gene therapy and hepatology: gene therapy